| abstract |
Compositions are disclosed for the prevention or treatment of MRSA infection in an individual, preferably a planktonic MRSA infection. The compositions comprise an enzyme that is able to convert a substrate to release hydrogen peroxide and a substance that includes a substrate for the said enzyme. The enzyme is additional to any enzyme activity able to convert the substrate to release hydrogen peroxide that may be present in the substance. The substance may be an unrefined natural substance, preferably honey or a substance that includes a purified substrate for the enzyme. The enzyme is preferably an oxidoreductase, more preferably a glucose oxidase. |